Cargando…
851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality
BACKGROUND: In the US, Staphylococcus aureus Bacteremia (SAB) occurs in about 19.7 /100,000 people. A recent increase in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia infections rate and mortality has led to more infectious diseases (ID) consultations. We assessed if an infectious di...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776014/ http://dx.doi.org/10.1093/ofid/ofaa439.1040 |
_version_ | 1783630581833138176 |
---|---|
author | Travez, Robert D Eagleston, Anjuli Brandt, Dominique Blatt, Stephen |
author_facet | Travez, Robert D Eagleston, Anjuli Brandt, Dominique Blatt, Stephen |
author_sort | Travez, Robert D |
collection | PubMed |
description | BACKGROUND: In the US, Staphylococcus aureus Bacteremia (SAB) occurs in about 19.7 /100,000 people. A recent increase in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia infections rate and mortality has led to more infectious diseases (ID) consultations. We assessed if an infectious diseases consultation within 7 days of initial blood culture results was associated to greater compliance with Infectious Diseases Society of America (IDSA) guidelines for managing Staphylococcus aureus bacteremia and a decrease in all-cause mortality and relapse within 90 days. METHODS: A retrospective cohort of patients admitted to two community hospitals from January 2014 to June 2016 with a positive blood culture for methicillin-susceptible S. aureus (MSSA), MRSA, or coagulase-negative Staphylococcus were included in the study. I. Patients were excluded if they were immunocompromised, had a polymicrobial blood stream infection, died within first 48 hours of admission, left against medical advice during treatment or participated in another study requiring an alternative treatment strategy. RESULTS: A total of 331 patients were included in the analysis. A significantly higher proportion of patients with complicated SAB had an ID consult (61% vs. 17.5%, p< .0001) and for uncomplicated SAB the reverse was true (39% vs 79%, P< .0001). An ID consult was associated with increased compliance with IDSA guidelines (75% vs. 5%, p< .0001). Patients with an ID consult had a significantly higher duration of antibiotic treatment [30(14-42) vs. 5(1.5-12), p< .0001], an earlier start of treatment in number of days [0(0-7) vs. 0(0-12), p=0.036] and a lower mortality within 90 days of blood culture (61% vs. 17.5%, p< .0001). Logistic regression model showed than an ID consult reduced 90-day mortality by 69%, OR 0.313[CI 95 %(0.313-0.154), p=0.001] and transesophageal echography by 78%, OR 0.228[CI 95 %(0.228-0.052), p=0.05]. Population characteristics and outcomes [Image: see text] CONCLUSION: ID consultation in the setting of SAB has been shown to increase compliance with IDSA guidelines and reduce 90-day mortality. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-7776014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77760142021-01-07 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality Travez, Robert D Eagleston, Anjuli Brandt, Dominique Blatt, Stephen Open Forum Infect Dis Poster Abstracts BACKGROUND: In the US, Staphylococcus aureus Bacteremia (SAB) occurs in about 19.7 /100,000 people. A recent increase in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia infections rate and mortality has led to more infectious diseases (ID) consultations. We assessed if an infectious diseases consultation within 7 days of initial blood culture results was associated to greater compliance with Infectious Diseases Society of America (IDSA) guidelines for managing Staphylococcus aureus bacteremia and a decrease in all-cause mortality and relapse within 90 days. METHODS: A retrospective cohort of patients admitted to two community hospitals from January 2014 to June 2016 with a positive blood culture for methicillin-susceptible S. aureus (MSSA), MRSA, or coagulase-negative Staphylococcus were included in the study. I. Patients were excluded if they were immunocompromised, had a polymicrobial blood stream infection, died within first 48 hours of admission, left against medical advice during treatment or participated in another study requiring an alternative treatment strategy. RESULTS: A total of 331 patients were included in the analysis. A significantly higher proportion of patients with complicated SAB had an ID consult (61% vs. 17.5%, p< .0001) and for uncomplicated SAB the reverse was true (39% vs 79%, P< .0001). An ID consult was associated with increased compliance with IDSA guidelines (75% vs. 5%, p< .0001). Patients with an ID consult had a significantly higher duration of antibiotic treatment [30(14-42) vs. 5(1.5-12), p< .0001], an earlier start of treatment in number of days [0(0-7) vs. 0(0-12), p=0.036] and a lower mortality within 90 days of blood culture (61% vs. 17.5%, p< .0001). Logistic regression model showed than an ID consult reduced 90-day mortality by 69%, OR 0.313[CI 95 %(0.313-0.154), p=0.001] and transesophageal echography by 78%, OR 0.228[CI 95 %(0.228-0.052), p=0.05]. Population characteristics and outcomes [Image: see text] CONCLUSION: ID consultation in the setting of SAB has been shown to increase compliance with IDSA guidelines and reduce 90-day mortality. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7776014/ http://dx.doi.org/10.1093/ofid/ofaa439.1040 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Travez, Robert D Eagleston, Anjuli Brandt, Dominique Blatt, Stephen 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title | 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title_full | 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title_fullStr | 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title_full_unstemmed | 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title_short | 851. Compliance with Guidelines for Management of Staphylococcus aureus Bacteremia and its Effect on Mortality |
title_sort | 851. compliance with guidelines for management of staphylococcus aureus bacteremia and its effect on mortality |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776014/ http://dx.doi.org/10.1093/ofid/ofaa439.1040 |
work_keys_str_mv | AT travezrobertd 851compliancewithguidelinesformanagementofstaphylococcusaureusbacteremiaanditseffectonmortality AT eaglestonanjuli 851compliancewithguidelinesformanagementofstaphylococcusaureusbacteremiaanditseffectonmortality AT brandtdominique 851compliancewithguidelinesformanagementofstaphylococcusaureusbacteremiaanditseffectonmortality AT blattstephen 851compliancewithguidelinesformanagementofstaphylococcusaureusbacteremiaanditseffectonmortality |